Rothesay Life bid for Swiss Re’s ReAssure could scupper IPO
Insurer Rothesay Life is mulling making a £3.5 billion bid for ReAssure, Swiss Re’s UK closed book business, potentially jeopardising plans to list the unit this year, according to reports.
Swiss Re confirmed late last year that it was continuing to explore an initial public offering (IPO) of the business. In preparation for the move, it also appointed Mark Hodges, the CEO of Centrica Consumer division, as CEO of ReAssure from 1 March 2019.
The reinsurer said the new CEO would steer the ReAssure business through an anticipated IPO in 2019 and will lead its next phase of expansion as an independent listed closed book consolidator.
It said the IPO would be necessary given the size of potential opportunities that are expected to arise in the market in the mid-term. It said it would be important for ReAssure to have access to substantial new capital to acquire additional closed books.
Swiss Re Life Capital CEO Thierry Léger said at the time: "We are very pleased to have Mark Hodges as the new CEO for ReAssure. He combines strong leadership skills with deep industry knowledge. I am confident that he is the right person to lead ReAssure through the next stage of its development into an even more successful future."
Both Rothesay Life and Swiss Re have not yet commented on the reports.
Get all the latest re/insurance industry news with our daily newsletter - sign up here.
More of today's news
Pool Re will no longer offer contingency cover against terrorist acts
Hamilton Underwriting poaches CFO from WR Berkley
Continental Re hires Swiss Re exec to spearhead new venture
Arthur J. Gallagher to acquire UK broker Stackhouse Poland
UK insurer Kingsbridge acquires insurtech firm Dinghy
R&Q subsidiary Accredited partners with motor MGA Kitsune
Inflexion completes investment in motor insurer Granite Underwriting
US commercial rates up by 2% in Q4
Willis Towers Watson makes senior EMEA appointment
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze